triazoles has been researched along with Alcoholism in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (4.76) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 10 (47.62) | 29.6817 |
| 2010's | 7 (33.33) | 24.3611 |
| 2020's | 3 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Bonomo, Y; Campbell, EJ; Lawrence, AJ; Norman, A | 1 |
| Liang, Y; Zhou, Y | 1 |
| Campbell, EJ; Lawrence, AJ; Marchant, NJ | 1 |
| Benedict, J; Ehlers, CL; Sanchez-Alavez, M; Wills, DN | 1 |
| Engel, JA; Fredriksson, I; Jerlhag, E; Steensland, P; Suchankova, P | 1 |
| Cunningham, CL; Fidler, TL; Finn, DA; Gomez, JL; Helpenstell, LK; Kosten, TA; Ryabinin, AE; Schuette, LM; Young, EA | 1 |
| Bullmore, ET; Maltby, K; Miller, SR; Mugnaini, M; Nathan, P; Ripley, TL; Sanchez-Roige, S; Stephens, DN; Wille, DR | 1 |
| Grosshans, M; Kiefer, F; Mutschler, J | 1 |
| Kuehn, BM | 1 |
| Duval, A; Hickman, G; Petit, A; Picard, C | 1 |
| Bartlett, SE; Engel, JA; Hyytiä, P; Jerlhag, E; Landgren, S; Simms, JA | 1 |
| Engin, E; Liu, J; Rudolph, U | 1 |
| Bobadilla, L; Brown, ES; Dhillon, H; Frol, A; Nejtek, VA; Perantie, D | 1 |
| Feinn, R; Hernandez-Avila, CA; Kranzler, HR; Modesto-Lowe, V | 1 |
| Anghelescu, I; Hautzinger, M; Lörch, B; Müller, MJ; Scheurich, A; Schläfke, D; Singer, P; Sittinger, H; Szegedi, A; Wetzel, H; Wobrock, T | 2 |
| Brandt, JE; Gehlert, DR; George, DT; Geyer, C; Gilman, J; Heilig, M; Herion, D; Hersh, J; Hommer, D; Hunt, SP; Kielbasa, W; Peng, X; Rawlings, R; Tauscher, JT; Thorsell, A | 1 |
| Miller, G | 1 |
| Kranzler, HR; Modesto-Lowe, V; Van Kirk, J | 1 |
| Blume, AW; Cowley, DS; Jaffe, C; Kingsley, E; Pages, KP; Ries, RK; Roy-Byrne, PP; Russo, JE | 1 |
| Fabre, LF; Gainey, A; Kemple, S | 1 |
3 review(s) available for triazoles and Alcoholism
| Article | Year |
|---|---|
Suvorexant to treat alcohol use disorder and comorbid insomnia: Plan for a phase II trial.
Topics: Alcoholism; Azepines; Benzodiazepines; Clinical Trials, Phase II as Topic; Comorbidity; Humans; Orexin Receptor Antagonists; Orexin Receptors; Sleep Initiation and Maintenance Disorders; Triazoles | 2020 |
A sleeping giant: Suvorexant for the treatment of alcohol use disorder?
Topics: Alcoholism; Animals; Azepines; Humans; Orexin Receptor Antagonists; Sleep Wake Disorders; Substance Withdrawal Syndrome; Triazoles | 2020 |
α2-containing GABA(A) receptors: a target for the development of novel treatment strategies for CNS disorders.
Topics: Alcoholism; Animals; Anxiety; Central Nervous System Diseases; Chronic Pain; Cognition Disorders; Depression; GABA-A Receptor Agonists; Humans; Polymorphism, Genetic; Pyridazines; Receptors, GABA-A; Schizophrenia; Substance-Related Disorders; Triazoles | 2012 |
7 trial(s) available for triazoles and Alcoholism
| Article | Year |
|---|---|
Open-label nefazodone in patients with a major depressive episode and alcohol dependence.
Topics: Adult; Affect; Alcoholism; Antidepressive Agents, Second-Generation; Anxiety; Depressive Disorder; Diagnosis, Dual (Psychiatry); Female; Humans; Male; Memory; Middle Aged; Piperazines; Treatment Outcome; Triazoles | 2003 |
Nefazodone treatment of comorbid alcohol dependence and major depression.
Topics: Adult; Alcoholism; Analysis of Variance; Chi-Square Distribution; Depressive Disorder, Major; Diagnosis, Dual (Psychiatry); Double-Blind Method; Female; Humans; Male; Middle Aged; Piperazines; Triazoles | 2004 |
[Combination treatment with SSRI and cognitive behavior therapy for relapse prevention of alcohol-dependent men. Results of a randomized, controlled multicenter therapeutic study].
Topics: Adult; Alcoholism; Cognitive Behavioral Therapy; Combined Modality Therapy; Disease-Free Survival; Germany; Humans; Male; Middle Aged; Piperazines; Prevalence; Risk Assessment; Risk Factors; Secondary Prevention; Treatment Outcome; Triazoles | 2005 |
Combination treatment with nefazodone and cognitive-behavioral therapy for relapse prevention in alcohol-dependent men: a randomized controlled study.
Topics: Adult; Alcoholism; Cognitive Behavioral Therapy; Combined Modality Therapy; Counseling; Diagnosis, Computer-Assisted; Humans; Male; Piperazines; Placebos; Psychiatric Status Rating Scales; Secondary Prevention; Treatment Outcome; Triazoles | 2004 |
Neurokinin 1 receptor antagonism as a possible therapy for alcoholism.
Topics: Adult; Aged; Alcohol Drinking; Alcoholism; Animals; Behavior, Addictive; Brain; Emotions; Ethanol; Female; Humans; Hydrocortisone; Magnetic Resonance Imaging; Male; Mice; Mice, Inbred C57BL; Middle Aged; Neurokinin-1 Receptor Antagonists; Pyridines; Receptors, Neurokinin-1; Triazoles | 2008 |
Naltrexone vs. nefazodone for treatment of alcohol dependence. A placebo-controlled trial.
Topics: Adult; Alcoholism; Antidepressive Agents, Second-Generation; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Naltrexone; Narcotic Antagonists; Patient Compliance; Piperazines; Receptor, Serotonin, 5-HT2A; Receptors, Serotonin; Recurrence; Selective Serotonin Reuptake Inhibitors; Time Factors; Triazoles | 2000 |
Nefazodone treatment of major depression in alcohol-dependent patients: a double-blind, placebo-controlled trial.
Topics: Adolescent; Adult; Alcoholism; Antidepressive Agents, Second-Generation; Combined Modality Therapy; Depressive Disorder, Major; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Piperazines; Psychotherapy, Group; Treatment Outcome; Triazoles | 2000 |
11 other study(ies) available for triazoles and Alcoholism
| Article | Year |
|---|---|
Involvement of GRK2 in modulating nalfurafine-induced reduction of excessive alcohol drinking in mice.
Topics: Alcoholism; Animals; Benzamides; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Ethanol; G-Protein-Coupled Receptor Kinase 2; G-Protein-Coupled Receptor Kinase 3; Humans; Male; Mice; Morphinans; Nucleus Accumbens; Pyridines; Receptors, Opioid, kappa; Spiro Compounds; Triazoles | 2021 |
Effect of suvorexant on event-related oscillations and EEG sleep in rats exposed to chronic intermittent ethanol vapor and protracted withdrawal.
Topics: Alcoholism; Animals; Azepines; Electroencephalography; Ethanol; Humans; Male; Orexin Receptor Antagonists; Rats; Rats, Wistar; Sleep Aids, Pharmaceutical; Sleep Initiation and Maintenance Disorders; Sleep Wake Disorders; Sleep, REM; Sleep, Slow-Wave; Substance Withdrawal Syndrome; Time Factors; Triazoles | 2019 |
Ghrelin receptor (GHS-R1A) antagonism suppresses both alcohol consumption and the alcohol deprivation effect in rats following long-term voluntary alcohol consumption.
Topics: Administration, Oral; Alcohol Drinking; Alcoholism; Animals; CpG Islands; DNA Methylation; Gene Expression Regulation; Ghrelin; Glycine; Male; Rats; Rats, Wistar; Receptors, Ghrelin; Self Administration; Signal Transduction; Substance Withdrawal Syndrome; Triazoles; Ventral Tegmental Area | 2013 |
Differential effects of ghrelin antagonists on alcohol drinking and reinforcement in mouse and rat models of alcohol dependence.
Topics: Alcohol Drinking; Alcoholism; Animals; Central Nervous System Agents; Conditioning, Operant; Disease Models, Animal; Dose-Response Relationship, Drug; Ethanol; Food Preferences; Ghrelin; Glycine; Male; Mice, Inbred C57BL; Random Allocation; Rats, Wistar; Receptors, Ghrelin; Reinforcement, Psychology; Self Administration; Triazoles | 2015 |
The novel mu-opioid antagonist, GSK1521498, reduces ethanol consumption in C57BL/6J mice.
Topics: Alcohol Drinking; Alcoholism; Animals; Autoradiography; Behavior, Animal; Central Nervous System Depressants; Cross-Over Studies; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Ethanol; Indans; Male; Mice; Mice, Inbred C57BL; Naltrexone; Narcotic Antagonists; Radiopharmaceuticals; Receptors, Opioid, mu; Self Administration; Triazoles; Tritium | 2015 |
[A new pharmacological treatment option for alcohol dependence discovered in transnational study: neurokinin-1 receptor antagonist as a possible therapy for alcoholism?].
Topics: Adult; Alcohol Deterrents; Alcoholism; Animals; Double-Blind Method; Female; Humans; Male; Mice; Mice, Knockout; Middle Aged; Neurokinin-1 Receptor Antagonists; Pyridines; Randomized Controlled Trials as Topic; Receptors, Neurokinin-1; Recurrence; Research; Substance P; Triazoles; Young Adult | 2008 |
Findings on alcohol dependence point to promising avenues for targeted therapies.
Topics: Alcoholism; Animals; Benzazepines; Humans; Naltrexone; Narcotic Antagonists; Neurokinin-1 Receptor Antagonists; Nicotinic Agonists; Pharmacogenetics; Pyridines; Quinoxalines; Receptors, Corticotropin-Releasing Hormone; Receptors, Opioid, mu; Stress, Psychological; Triazoles; Varenicline | 2009 |
[Porphyria cutanea tarda revealed by voriconazole].
Topics: Aged; Alcoholism; Antifungal Agents; Cheilitis; Feces; Humans; Liver; Male; Photosensitivity Disorders; Porphyria Cutanea Tarda; Porphyrins; Pulmonary Aspergillosis; Pyrimidines; Triazoles; Uroporphyrinogen Decarboxylase; Voriconazole | 2010 |
Ghrelin receptor (GHS-R1A) antagonism suppresses both operant alcohol self-administration and high alcohol consumption in rats.
Topics: Alcohol Drinking; Alcoholism; Analysis of Variance; Animals; Central Nervous System Depressants; Choice Behavior; Conditioning, Operant; Disease Models, Animal; Ethanol; Glycine; Male; Rats; Rats, Long-Evans; Receptors, Ghrelin; Self Administration; Signal Transduction; Triazoles | 2012 |
Psychopharmacology. Tackling alcoholism with drugs.
Topics: Alcohol Deterrents; Alcoholism; Animals; Controlled Clinical Trials as Topic; Emotions; Humans; Neurokinin-1 Receptor Antagonists; Pyridines; Receptors, Corticotropin-Releasing Hormone; Reward; Stress, Psychological; Triazoles | 2008 |
Pilot open-label study of alprazolam (U-31,889) in anxious alcoholic out-patients.
Topics: Adult; Alcoholism; Ambulatory Care; Anti-Anxiety Agents; Anxiety; Benzodiazepines; Drug Evaluation; Female; Humans; Male; Middle Aged; Pilot Projects; Psychiatric Status Rating Scales; Substance Withdrawal Syndrome; Triazoles | 1977 |